BioCardia (BCDA) Revenue (2011 - 2024)
BioCardia's (BCDA) quarterly Revenue came in at $3000.0 in Q2 2024, down 93.02% year-over-year from $43000.0 in Q3 2023, and down 94.55% quarter-over-quarter from $55000.0 in Q1 2024.
Powered by 
Analysis
BioCardia (BCDA) Revenue (2011 - 2024) Analysis & Trends
BioCardia (BCDA) has reported Revenue for 12 consecutive years, with $3000.0 the latest figure, recorded in Q2 2024.
- On a quarterly basis, Revenue fell 93.02% year-over-year to $3000.0 in Q2 2024; TTM through Mar 2025 was $3000.0, a 99.36% decrease from a year earlier, with the FY2024 full-year figure at $58000.0, down 87.84% from the prior year.
- Revenue was $3000.0 for Q2 2024 at BioCardia, down from $55000.0 in the prior quarter.
- Over five years, Revenue peaked at $974000.0 in Q2 2022 and troughed at $3000.0 in Q2 2024.
- A 5-year average of $169277.8 and a median of $57500.0 in 2022 frame the typical range for Revenue.
- Across the five-year window, Revenue soared 2314.71% in 2021 and sank 95.59% in 2023, its largest moves.
- Over 5 years, Revenue stood at $46000.0 in 2020, then jumped by 71.74% to $79000.0 in 2021, then jumped by 34.18% to $106000.0 in 2022, then plunged by 87.74% to $13000.0 in 2023, then slumped by 76.92% to $3000.0 in 2024.
- The last three Revenue figures came in at $3000.0 (Q2 2024), $55000.0 (Q1 2024), and $13000.0 (Q4 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | 119.22 Mn |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | 10.18 Mn |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 99.31 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | 387.50 Mn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | 5.84 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | 490,000.00 |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | 54.98 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | 401.25 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 77.46 Mn |
| 10 | BioCardia | 13.06 Mn | 8.94 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 55,000.00 |
| Dec 31, 2023 | 13,000.00 |
| Sep 30, 2023 | 357,000.00 |
| Jun 30, 2023 | 43,000.00 |
| Mar 31, 2023 | 64,000.00 |
| Dec 31, 2022 | 106,000.00 |
| Sep 30, 2022 | 212,000.00 |
| Jun 30, 2022 | 974,000.00 |
| Mar 31, 2022 | 60,000.00 |
| Dec 31, 2021 | 79,000.00 |
| Sep 30, 2021 | 821,000.00 |
| Jun 30, 2021 | 69,000.00 |
| Mar 31, 2021 | 46,000.00 |
| Dec 31, 2020 | 46,000.00 |
| Sep 30, 2020 | 34,000.00 |
| Jun 30, 2020 | 27,000.00 |
| Mar 31, 2020 | 38,000.00 |
| Dec 31, 2019 | 215,000.00 |
| Sep 30, 2019 | 194,000.00 |